GB0130576D0 - Dopamine D1 receptor agonist pro-drug compounds & derivatives - Google Patents

Dopamine D1 receptor agonist pro-drug compounds & derivatives

Info

Publication number
GB0130576D0
GB0130576D0 GBGB0130576.2A GB0130576A GB0130576D0 GB 0130576 D0 GB0130576 D0 GB 0130576D0 GB 0130576 A GB0130576 A GB 0130576A GB 0130576 D0 GB0130576 D0 GB 0130576D0
Authority
GB
United Kingdom
Prior art keywords
dopamine
derivatives
receptor agonist
drug compounds
agonist pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0130576.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paion UK Ltd
Original Assignee
Cenes Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cenes Ltd filed Critical Cenes Ltd
Priority to GBGB0130576.2A priority Critical patent/GB0130576D0/en
Publication of GB0130576D0 publication Critical patent/GB0130576D0/en
Priority to PCT/GB2002/005809 priority patent/WO2003053936A1/en
Priority to AU2002352474A priority patent/AU2002352474A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0130576.2A 2001-12-20 2001-12-20 Dopamine D1 receptor agonist pro-drug compounds & derivatives Ceased GB0130576D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0130576.2A GB0130576D0 (en) 2001-12-20 2001-12-20 Dopamine D1 receptor agonist pro-drug compounds & derivatives
PCT/GB2002/005809 WO2003053936A1 (en) 2001-12-20 2002-12-19 Dopamine d1 receptor agonist pro-drug compounds & derivatives
AU2002352474A AU2002352474A1 (en) 2001-12-20 2002-12-19 Dopamine d1 receptor agonist pro-drug compounds and derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0130576.2A GB0130576D0 (en) 2001-12-20 2001-12-20 Dopamine D1 receptor agonist pro-drug compounds & derivatives

Publications (1)

Publication Number Publication Date
GB0130576D0 true GB0130576D0 (en) 2002-02-06

Family

ID=9928104

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0130576.2A Ceased GB0130576D0 (en) 2001-12-20 2001-12-20 Dopamine D1 receptor agonist pro-drug compounds & derivatives

Country Status (3)

Country Link
AU (1) AU2002352474A1 (en)
GB (1) GB0130576D0 (en)
WO (1) WO2003053936A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070232590A1 (en) * 2004-06-18 2007-10-04 Glaxo Group Limited 3-Cylcoalkylbenzazepines as Histamine H3 Antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561305A (en) * 1975-07-02 1980-02-20 Smithkline Corp Benzazepine derivatives and pharmeceutical compositions containing them
US4052506A (en) * 1975-08-05 1977-10-04 Smithkline Corporation Pharmaceutical compositions and method of producing anti-parkinsonism activity
DK325188D0 (en) * 1988-06-15 1988-06-15 Novo Industri As BENZAZEPINE DERIVATIVES UNKNOWN
US4861771A (en) * 1989-01-27 1989-08-29 Smithkline Beckman Corporation Carbamates of 6-chloro-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine as prodrugs
DK23392D0 (en) * 1992-02-24 1992-02-24 Novo Nordisk As Heterocyclic Compounds, Their Uses and Preparation
GB9903671D0 (en) * 1999-02-17 1999-04-14 Cenes Ltd Dopamine D-1 receptor agonist compounds

Also Published As

Publication number Publication date
WO2003053936A1 (en) 2003-07-03
AU2002352474A1 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
AU2002210782A1 (en) Amide derivatives as nmda receptor antagonists
HK1091403A1 (en) 5-ht 1a receptor subtype agonist
ZA200510104B (en) Crystalline form of beta2 adrenergic receptor agonist
AU2003259229A1 (en) CRYSTALLINE Beta2 ADRENERGIC RECEPTOR AGONIST
AU2708901A (en) Compounds exhibiting thrombopoietin receptor agonism
PT1347760E (en) PHARMACEUTICAL COMPOUNDS OF NMDA RECEPTOR AGONIST
HK1069111A1 (en) Pharmaceutical composition comprising a 5ht1 receptor agonist.
AU4274401A (en) Diphenylalkylamine derivatives useful as opioid delta receptor agonists
IL161578A0 (en) Peroxisome proliferator activated receptor agonists
PL358593A1 (en) Estrogen agonist/antagonist metabolites
AU2001240097A1 (en) G protein-coupled receptors
PL349838A1 (en) Dopamine d1 receptor agonist compounds
IL150272A0 (en) Indole derivatives as mcp-1 receptor antagonists
AU2003244313A1 (en) Androgen receptor agonist
GB0130576D0 (en) Dopamine D1 receptor agonist pro-drug compounds & derivatives
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
GB0020710D0 (en) Dopamine D1 receptor agonist pro-drug compounds & derivatives
AU2003297408A1 (en) Thiazole compounds as integrin receptor antagonists derivatives
AU2001249922A1 (en) G protein-coupled receptors
AU2002302774A1 (en) Macrophage receptor agonist or antagonist
AU2825100A (en) Heterocyclic compounds having affinities for serotonin receptors
SI1347760T1 (en) Nmda receptor agonist pharmaceutical compositions
AU2001263346A1 (en) G protein-coupled receptors
AU2001279117A1 (en) G protein-coupled receptors
AU2001259612A1 (en) G protein-coupled receptors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)